NUCB1: A Protein Potential Drug Target for Neurodegenerative Diseases

Target Name: NUCB1

NCBI ID: G4924

NUCB1

NUCB1: A Protein Potential Drug Target for Neurodegenerative Diseases

NUCB1, also known as OTTHUMP00000201853, is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell growth and differentiation, and has been identified as a potential drug target in the field of neurodegenerative diseases.

NUCB1 was first identified in the 1990s as a regulator of cell adhesion and migration. Subsequently, it was shown to play a role in the regulation of neural stem cell proliferation and the development of neural circuits. NUCB1 has also been shown to be involved in the regulation of cancer cell growth and the development of cancer stem cells.

In addition to its role in cell biology, NUCB1 has also been shown to be involved in the regulation of inflammation and immune responses. It has been shown to play a role in the regulation of T cell development and function, as well as the regulation of inflammation in the brain.

Given its involvement in a wide range of cellular processes, NUCB1 has been identified as a potential drug target for a variety of neurodegenerative diseases. Studies have shown that modulating NUCB1 activity can lead to therapeutic benefits in conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis.

One approach to targeting NUCB1 is to use small molecules that can modulate its activity. For example, a class of drugs called inhibitors of the protein kinase CKL (K pigment) have been shown to be effective in modulating NUCB1 activity and have been shown to be effective in treating neurodegenerative diseases.

Another approach to targeting NUCB1 is to use antibodies that can specifically recognize and target the protein. This approach has been shown to be effective in modulating NUCB1 activity and has been used to treat a variety of neurodegenerative diseases.

In addition to its potential as a drug target, NUCB1 has also been shown to be a valuable biomarker for the diagnosis and progression of neurodegenerative diseases. For example, NUCB1 levels have been shown to be decreased in the brains of individuals with Alzheimer's disease, and have been used as a biomarker for the disease in clinical trials.

Overall, NUCB1 is a protein that has significant potential as a drug target for the treatment of neurodegenerative diseases. Further research is needed to fully understand its role in cell biology and its potential as a therapeutic target.

Protein Name: Nucleobindin 1

Functions: Major calcium-binding protein of the Golgi which may have a role in calcium homeostasis (By similarity). Acts as a non-receptor guanine nucleotide exchange factor which binds to and activates alpha subunits of guanine nucleotide-binding proteins (G proteins) (By similarity)

The "NUCB1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NUCB1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets